Repression of PXR-mediated induction of hepatic CYP3A gene expression by protein kinase C

被引:85
作者
Ding, XS [1 ]
Staudinger, JL [1 ]
机构
[1] Univ Kansas, Lawrence, KS 66045 USA
关键词
pregnane X receptor; CYP3A; PMA; PCN; PKC; inflammation;
D O I
10.1016/j.bcp.2004.11.025
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pregnane X receptor (PXR, NR112) regulates the inducible expression of the 3A sub-family of cytochrome P450 genes (CYP3A). CYP3A enzymes are responsible for the oxidative metabolism of a wide array of endobiotic and xenobiotic compounds. Hepatic CYP3A gene expression is rapidly down-regulated during inflammation and sepsis. There are twelve protein kinase C (PKC) isoforms, classified into three subfamilies according to the structure of the N-terminal regulatory domain and their sensitivity to calcium and diacylglycerol. It is now well accepted that cytokine stimulation of hepatocytes increases intracellular PKC activity during inflammation and sepsis. We show here that protein kinase C alpha (PKCalpha) and phorbol ester-dependent PKC signaling dramatically repressed PXR activity in both, cell-based reporter gene assays and in hepatocytes. Moreover, treatment with the protein phosphatase PP1/PP2A inhibitor okadaic acid (OA) totally abolished PXR activity in reporter gene assays and in cultured hepatocytes. In mammalian two-hybrid assays, treatment with phorbol 12-myristate 13-acetate (PMA) increased the strength of interaction between PXR and the nuclear receptor co-repressor protein (NCoR). Treatment with PMA also abolished the ligand-dependent interaction between PXR and the steroid receptor co-activator 1 protein (SRC 1). Our findings suggest that activation of the protein kinase C signaling pathway represses PXR activity through alterations in PXR-protein co-factor complexes, possibly through direct alterations in the phosphorylation status of one or all of these proteins. In addition, our data potentially provide important insights into the molecular mechanism of the repression of hepatic CYP3A gene expression that occurs during the inflammatory response. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:867 / 873
页数:7
相关论文
共 34 条
  • [1] ABDELRAZZAK Z, 1993, MOL PHARMACOL, V44, P707
  • [2] Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression
    Alland, L
    Muhle, R
    Hou, H
    Potes, J
    Chin, L
    SchreiberAgus, N
    DePinho, RA
    [J]. NATURE, 1997, 387 (6628) : 49 - 55
  • [3] IN-VIVO AND IN-VITRO PHOSPHORYLATION OF THE HUMAN ESTROGEN-RECEPTOR
    ARNOLD, SF
    OBOURN, JD
    YUDT, MR
    CARTER, TH
    NOTIDES, AC
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 52 (02) : 159 - 171
  • [4] Phosphorylation of Ser(211) in the chicken progesterone receptor modulates its transcriptional activity
    Bai, WL
    Weigel, NL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) : 12801 - 12806
  • [5] TUMOR-NECROSIS-FACTOR PRODUCTION BY KUPFFER CELLS REQUIRES PROTEIN-KINASE-C ACTIVATION
    BANKEY, P
    CARLSON, A
    ORTIZ, M
    SINGH, R
    CERRA, F
    [J]. JOURNAL OF SURGICAL RESEARCH, 1990, 49 (03) : 256 - 261
  • [6] Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction
    Bertilsson, G
    Heidrich, J
    Svensson, K
    Åsman, M
    Jendeberg, L
    Sydow-Bäckman, M
    Ohlsson, R
    Postlind, H
    Blomquist, P
    Berkenstam, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) : 12208 - 12213
  • [7] SXR, a novel steroid and xenobiotic-sensing nuclear receptor
    Blumberg, B
    Sabbagh, W
    Juguilon, H
    Bolado, J
    van Meter, CM
    Ono, ES
    Evans, RM
    [J]. GENES & DEVELOPMENT, 1998, 12 (20) : 3195 - 3205
  • [8] BODWELL JE, 1991, J BIOL CHEM, V266, P7549
  • [9] Guggulsterone activates multiple nuclear receptors and induces CYP3A gene expression through the pregnane X receptor
    Brobst, DE
    Ding, XS
    Creech, KL
    Goodwin, B
    Kelley, B
    Staudinger, JL
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (02) : 528 - 535
  • [10] DING X, IN PRESS J PHARM EXP